Saxenda (liraglutide) prior authorization denied appeal
GLP-1 for weight management
Typical PA criteria
- BMI 30 or 27 with comorbidity
- Lifestyle intervention documented
Why your PA was denied
- Plan excludes weight-loss drugs
- Step therapy required
Evidence that overturns the denial
- ✓BMI history
- ✓Comorbidity codes
- ✓Prior weight-loss attempts
Older anti-obesity GLP-1; often required as step therapy before Wegovy in some plans.
Free analysis identifies the cited policy and missing evidence. Then a finished letter that maps your chart to the criteria.
FAQ
Why was my Saxenda (liraglutide) prior authorization denied?+
The most common reasons are: Plan excludes weight-loss drugs; Step therapy required. Your denial letter names the specific criteria you did not meet.
How do I appeal a Saxenda (liraglutide) denial?+
File a written appeal within 180 days that cites the insurer's clinical policy, includes a letter of medical necessity from the prescriber, and documents the criteria the insurer requires.
What evidence overturns a Saxenda (liraglutide) denial?+
BMI history; Comorbidity codes; Prior weight-loss attempts.
What if the plan excludes Saxenda (liraglutide) entirely?+
Plan exclusions are different from medical-necessity denials. Check the Summary Plan Description. If the drug is fully excluded, an appeal will not overturn it; you may need a formulary exception or manufacturer assistance program.
Other drugs
- Wegovy (semaglutide)
- Zepbound (tirzepatide)
- Ozempic (semaglutide)
- Mounjaro (tirzepatide)
- Humira (adalimumab)